Islay Capital Management’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$578K Sell
1,973
-499
-20% -$164K 0.29% 73
2025
Q4
$867K Buy
+2,472
New +$835K 0.51% 57
2025
Q3
Sell
-35
Closed -$13.6K 219
2025
Q2
$13.6K Hold
35
0.01% 151
2025
Q1
$15.2K Sell
35
-2,061
-98% -$827K 0.01% 144
2024
Q4
$773K Buy
2,096
+1,969
+1,550% +$824K 0.54% 56
2024
Q3
$66K Hold
127
0.04% 117
2024
Q2
$68.8K Hold
127
0.05% 116
2024
Q1
$65.9K Hold
127
0.05% 115
2023
Q4
$59.9K Hold
127
0.05% 125
2023
Q3
$55.3K Hold
127
0.05% 124
2023
Q2
$56.4K Hold
127
0.05% 122
2023
Q1
$58.4K Hold
127
0.06% 124
2022
Q4
$65.1K Hold
127
0.07% 115
2022
Q3
$58K Sell
127
-180
-59% -$86.1K 0.07% 127
2022
Q2
$148K Hold
307
0.15% 97
2022
Q1
$151K Hold
307
0.13% 109
2021
Q4
$142K Sell
307
-100
-25% -$42.1K 0.11% 118
2021
Q3
$152K Hold
407
0.12% 90
2021
Q2
$155K Hold
407
0.13% 89
2021
Q1
$146K Sell
407
-140
-26% -$45K 0.12% 98
2020
Q4
$176K Hold
547
0.16% 75
2020
Q3
$147K Buy
547
+362
+196% +$97.4K 0.15% 76
2020
Q2
$49K Hold
185
0.06% 168
2020
Q1
$42K Buy
185
+6
+3% +$1.64K 0.06% 158
2019
Q4
$54K Buy
+179
New +$49.3K 0.05% 163

Other funds holding ELV

Islay Capital Management's ELV Position: Q1 2026 in Review

Islay Capital Management reduced its Elevance Health (ELV) stake by 20% in Q1 2026, selling an estimated $164K and leaving 1,973 shares worth $578K. The position accounts for 0.29% of the portfolio, ranked #73.

Islay Capital Management first reported a position in ELV in Q4 2019 and has held it in 25 quarters since. The position peaked at $867K in Q4 2025. 1,462 funds tracked by Wall St. Rank hold ELV as of Q1 2026.

  • Islay Capital Management held 1,973 shares of Elevance Health worth $578K as of Q1 2026.
  • Islay Capital Management sold 499 Elevance Health shares in Q1 2026, an estimated $164K.
  • Elevance Health made up 0.29% of Islay Capital Management's portfolio in Q1 2026, its #73 holding.
  • Islay Capital Management first reported a position in Elevance Health in Q4 2019 and has held it in 25 quarters since.
  • Islay Capital Management's Elevance Health position peaked at $867K in Q4 2025.
  • 1,462 funds tracked by Wall St. Rank held Elevance Health as of Q1 2026.

Based on Islay Capital Management's 13F filing for Q1 2026, filed 14 May 2026.